Clayton Stuart Rose, Director at LEXICON PHARMACEUTICALS, INC./DE (LXRX), bought 15,000 shares at $3.19 ($48K) on 2007-06-26, disclosed to the SEC on 2007-06-27.
Open-market purchase of $48k LXRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.